Bio-Rad Laboratories, Inc. (NYSE:BIO) agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) for $100 million on August 3, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
165 PLN | -0.96% |
|
-2.83% | -15.82% |
1st Jan change | Capi. | |
---|---|---|
-15.82% | 112M | |
-44.13% | 7.63B | |
+12.75% | 3.73B | |
-0.62% | 2.26B | |
-21.56% | 1.98B | |
-22.28% | 1.63B | |
+10.23% | 959M | |
-5.90% | 720M | |
+12.83% | 705M | |
-35.92% | 463M |
- Stock Market
- Equities
- SCP Stock
- News Scope Fluidics S.A.
- Bio-Rad Laboratories, Inc. agreed to acquire Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. for $100 million.